We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > GigaGen

News List

GigaGen Initiates Large-Scale Manufacturing of GIGA-2050 contractpharma
September 24, 2020
GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, has initiated large-scale manufacturing of its recombinant hyperimmune drug for COVID-19 ...
GigaGen develops new class of drugs to treat Covid-19 pharmaceutical-technology
August 11, 2020
US-based biotechnology company GigaGen has developed a new class of drugs, called recombinant hyperimmunes, to potentially treat patients with Covid-19.
GigaGen works on recombinant polyclonal antibody against Covid-19 pharmaceutical-technology
April 01, 2020
Biotechnology company GigaGen is working on a recombinant polyclonal antibody, recombinant anti-coronavirus 19 hyperimmune gammaglobulin (rCIG), as a Covid-19 treatment.